Detalhe da pesquisa
1.
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
Am J Hematol
; 99(4): 523-533, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247315
2.
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials.
PLoS Med
; 17(11): e1003323, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147277
3.
Bone marrow morphologic features, MyPRS, and gene mutation correlations in plasma cell myeloma.
Mod Pathol
; 33(2): 188-195, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375765
4.
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.
Blood
; 132(1): 59-66, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784643
5.
Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
Br J Haematol
; 184(4): 578-593, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408155
6.
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
Blood
; 130(1): 30-34, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28432222
7.
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.
Lancet
; 389(10068): 519-527, 2017 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017406
8.
MAF protein mediates innate resistance to proteasome inhibition therapy in multiple myeloma.
Blood
; 128(25): 2919-2930, 2016 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793878
9.
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma.
Blood
; 128(13): 1735-44, 2016 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27516441
10.
Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.
Blood
; 127(15): 1896-906, 2016 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755711
11.
Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma.
Haematologica
; 103(6): 1047-1053, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567784
12.
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
Lancet Oncol
; 18(4): e206-e217, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28368259
13.
Prospective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy.
Blood
; 126(22): 2475-8, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26468228
14.
Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.
Blood
; 125(24): 3756-9, 2015 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25943786
15.
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
Am J Hematol
; 92(8): 739-745, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28383130
16.
The effect of novel therapies in high-molecular-risk multiple myeloma.
Clin Adv Hematol Oncol
; 15(11): 870-879, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29200420
17.
High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapse.
Br J Haematol
; 195(2): 283-286, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244996
18.
The future of autologous stem cell transplantation in myeloma.
Blood
; 124(3): 328-33, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894774
19.
Curing myeloma at last: defining criteria and providing the evidence.
Blood
; 124(20): 3043-51, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293776
20.
Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120).
Blood
; 123(1): 78-85, 2014 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24144643